CDSCO Clarifies Export NOC Requirements for Approved r-DNA Products
The Central Drugs Standard Control Organization (CDSCO) has issued a clarification stating that pharmaceutical companies may not need a separate Export No Objection Certificate (NOC) for certain already approved recombinant DNA (r-DNA) drug products intended for export.











